{
    "title": "Glaxosmithkline snaps up US rival Bristol-Myers Squibb\u2019s HIV treatments worth up to \u00a3974.6m",
    "url": "https://www.dailymail.co.uk/money/news/article-3366437/GlaxoSmithKline-swoops-rival-Bristol-Myers-Squibb-s-974m-HIV-treatment.html",
    "date": "2015-12-18",
    "keywords": [
        "drug",
        "deal",
        "share",
        "business",
        "hiv",
        "string",
        "multibillion",
        "dollar",
        "competition",
        "patentfree",
        "time",
        "johnson",
        "astrazeneca",
        "respiratory",
        "fraud",
        "fund",
        "glaxommithkline",
        "industry",
        "giant",
        "companys",
        "viiv",
        "healthcare",
        "research",
        "development",
        "fostemsavir",
        "therapy",
        "designation",
        "approval",
        "medicinesthe",
        "city",
        "move",
        "glaxos",
        "subject",
        "takeover",
        "talk",
        "stock",
        "peak",
        "year",
        "glaxo",
        "roche",
        "switzerland",
        "price",
        "glaxosmithkline",
        "partnership",
        "drugmaker",
        "article",
        "chairman",
        "david",
        "redfern",
        "leadership",
        "innovation",
        "week",
        "core",
        "group",
        "stake",
        "pharma",
        "month",
        "shire",
        "swoop",
        "angioedema",
        "treatment",
        "developer",
        "dyaxmeanwhile",
        "entrepreneur",
        "martin",
        "shkreli",
        "company",
        "hedge",
        "manager"
    ],
    "category": [
        "money",
        "news"
    ]
}